| Literature DB >> 35178199 |
Ahmad Ali Eslami1, Sedigheh Shariatinia1, Mohadeseh Khoshgoftar2.
Abstract
BACKGROUND: Psychotropic drugs can cause many complications and side effects including cognitive, behavioral, and psychological disorders. In recent years, the Iranian youth and adolescents have growingly been using psychotropic drugs. Therefore, this study analyzes the overall prevalence of psychotropic drugs and the relevant factors among the Iranian youth through a systematic review and a meta-analysis.Entities:
Keywords: Adolescent; Iran; Meta-analysis; Psychotropic drugs
Year: 2021 PMID: 35178199 PMCID: PMC8818306 DOI: 10.22122/ahj.v13i4.1195
Source DB: PubMed Journal: Addict Health ISSN: 2008-4633
Characteristics of selected articles in the present study
| Author | Gender | Number | Type of study | City | Age group (year) | Mean of age (year) | Prevalence (%) |
|---|---|---|---|---|---|---|---|
| Poorasl et al.13 | Total | 1785 | Cross-sectional | Tabriz | 15-19 | 16.25 | 2.20 |
| Hamdieh et al.14 | Male | 4444 | Cross-sectional | Tehran | 15-35 | 21.00 | 2.80 |
| Female | 2731 | 1.02 | |||||
| Total | 8175 | 3.80 | |||||
| Rahimi Pordanjani et al.17 | Male | 122 | Cross-sectional | Yazd | 21-25 | 21.97 | 4.00 |
| Female | 128 | 1.60 | |||||
| Total | 250 | 5.60 | |||||
| Ghavidel et al.18 | Total | 400 | Cross-sectional | Nazar Abad | 15-20 | 17.30 | 1.50 |
| Ashrafi Hafez and Fakor Ziba19 | Male | 220 | Cross-sectional | Shiraz | 18-22 | - | 8.50 |
| Female | 420 | 1.30 | |||||
| Total | 640 | 9.80 |
Figure 1The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart for the selection of the eligible studies for meta-analysis
Investigating the relationship between the use of psychotropic drugs and background variables in Iranian youth
| Author | Age | Gender | Marital status | Daily exposure to smoking | Smoking parents | History of drug use | Smoking friends |
|---|---|---|---|---|---|---|---|
| Rahimi Pordanjani et al.17 | 0.030 | 0.080 | 0.250 | < 0.001 | 0.001 | 0.010 | - |
| Ashrafi Hafez and Fakor Ziba19 | 0.330 | < 0.001 | 0.003 | 0.001 | - | - | - |
| Ghavidel et al.18 | - | 0.001 | - | - | - | - | - |
| Hamdieh et al.14 | - | < 0.050 | < 0.050 | - | - | - | - |
| Poorasl et al.13 | 0.003 | - | - | 0.700 | - | 0.040 | 0.019 |
The values reported in the table are the significant values reported between the background variables and the prevalence of psychotropic drugs.
Figure 2The overall prevalence of psychotropic drugs and their 95% confidence interval (CI) in studies based on men and women
Figure 3The overall prevalence of psychotropic drugs and their 95% confidence interval (CI) in studies based on the model of random effects. Due to the heterogeneity of studies (93.1% = and P < 0.001), the model method of random effects has been used to estimate the overall prevalence and CI
Figure 4Funnel plot of studies